Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Hormone or other secreted growth regulatory factor,...
Reexamination Certificate
2006-05-02
2006-05-02
Crouch, Deborah (Department: 1632)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Hormone or other secreted growth regulatory factor,...
C530S350000
Reexamination Certificate
active
07037505
ABSTRACT:
The present invention relates to an immunological enhancement agent, more particularly, to an immunological enhancement agent comprising peptide having an amino acid sequence represented by SEQ ID NO:1 to SEQ ID NO:3 as an effective component.The peptides according to the present invention comprising the N-terminal domain of the p43 protein have excellent cytokine activity to improve an immune response so that they can be used as an effective immunological enhancement agent.
REFERENCES:
patent: WO 00/73801 (2000-12-01), None
Abbas et al., (1994) Cellular and Molecular Immunology 2nd ed., p. 75.
Norcum et al. (2000) The Cytokine Portion of p43 Occupies a Central Position within the Eukaryotic Multisynthetase Complex J. Bio. Chem. 275:17921-17924.
Ross et al. (2001) A compaison of gene espressin signatures from breast tumors and breast tissue derived lines. Disease Markers. 17:99-109.
Quevillon, S. et al. “The p43 Component of the Mammalian Multi-synthetase Complex Is Likely to be the Precursor of the Endothelial Monocyte-activating Polypetide II Cytokine”, J.Biol.Chem. (1997), vol. 272, No. 51, pp. 32573-32579, The American Society for Biochemistry and Molecular Biology, Inc.
Behrensdorf, H. et al. “The endothelial monocyte-activating polypeptide II (EMAP II) is a substrate for caspase-7” FEBS Lett., (2000), vol. 466, pp. 143-147, Federation of European Biochemical Societies.
Kao, J. et al. “A Peptide Derived from the Amino Terminus of Endothelial-Monocyte-activating Polypeptide II Modulates Mononuclear and Polymorphonuclear Leukocyte Functions, Defines an Apparently Novel Cellular Interaction Site, and Induces an Acute Inflammatory Response”, J. Biol. Chem. (1994), vol. 269, No. 13, pp. 9774-9782, The American Society for Biochemistry and Molecular Biology, Inc.
Kao, J. et al. “Endothelial Monocyte-activating Polypeptide II: A Novel Tumor-Derived Polypeptide That Activates Host-Response Mechanisms”, J. Biol. Chem. (1992), vol. 267, No. 28, pp. 20239-20247, The American Society for Biochemistry and Molecular Biology, Inc.
Kao, J. et al. “Characterization of a Novel Tumor-derived Cytokine: Endothelial-Monocyte Activiting”, J. Biol. Chem. (1994), vol. 269, No. 40, pp. 25106-25119, The American Society for Biochemistry and Molecular Biology, Inc.
Knies, U.E. et al., “Regulation of endothelial monocyte-activating polypeptide II release by apoptosis”, Proc. Natl. Acad. Sci. USA (1998), vol. 95, pp. 12322-12337.
Schwarz, M.A. et al., “Endothelial-Monocyte Activating Polypeptide II, A Novel Antitumor Cytokine that Suppresses Primary and Metastatic Tumor Growth and Induces Apoptosis in Growing Endothelial Cells”, J. Exp. Med. (1999) vol. 190, No. 3, pp. 341-352, The Rockefeller University Press.
Tas, M.P.R. and Murray, J.C., “Endothelial-Monocyte-Activating Polypeptide II”, Int. J. Biochem. Cell. Biol. (1996), vol. 28, No. 8, pp. 837-841, 1996 Elsevier Science Ltd.
Schluesener, H.J. et al., “Localization of Endothelial-Monocyte-Activating Polypeptide II (EMAP II), a Novel Proinflammatory Cytokine, to Lesions of Experimental Autoimmune Encephalomyelitis, Neuritis, and Uveitis”, GLIA (1997), vol. 20, pp. 365-372, Wiley-Liss, Inc.
Berger, A.C. et al., “Endothelial Monocyte-Activating Polypeptide II, a Tumor-Derived Cytokine That Plays an Important Role in Inflammation, Apoptosis, and Angiogenesis”, J. Immunother. (2000), vol. 23, No. 5, pp. 519-527, Lippincott, Williams and Wilkins, Inc.
Ko, Y.G. et al., “A Cofactor of tRNA Synthetase, p43, Is Secreted to Up-regulate Proinflammatory Genes”, J. Biol. Chem. (2001), vol. 276, No. 25, pp. 23026-23033, The American Society for Biochemistry and Molecular Biology, Inc.
Park, S.G. et al., “Precursor of Pro-apoptotic Cytokine Modulates Aminoacylation Activity of tRNA Synthetase”, J. Biol. Chem. (1999), vol. 274, No. 24, pp. 16673-16676, The American Society for Biochemistry and Molecular Biology, Inc.
Kim Sung-hoon
Ko Young-Gyu
Crouch Deborah
Foley & Lardner LLP
Imagene Co., Ltd.
Lieto Louis D.
LandOfFree
Method of inducing production of IL-8 or TNF by in vitro... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing production of IL-8 or TNF by in vitro..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing production of IL-8 or TNF by in vitro... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614205